PMD Device Solutions AB reported a 5x increase in net sales to kSEK 10,082 in Q4 2023, driven by RespiraSense product sales.
PMD Device Solutions AB released its Year-end report for April-December 2023, showing a 5x increase in net sales to kSEK 10,082, driven by 100% sales from RespiraSense related products. Consumable RespiraSense sensors accounted for 89% of total sales. There were no sales from Promore Pharma or Hospital-At-Home during this period. The gross margin was 78%, EBITDA was kSEK -9,007, and the loss after financial items was kSEK -14,087. Cash and cash equivalents as of December 31, 2023, were kSEK 1,284.
February 29, 2024
4 Articles